Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lincoln Pharmaceuticals Ltd. launches Ayurvedic Product 'ISL Granules' to serve mother and child healthcare segment

 Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 18, 2011 titled "Lincoln Pharmaceuticals Ltd. launches Ayurvedic Product 'ISL Granules' to serve mother and child healthcare segment"Press Release:" Lincoln Pharmaceuticals Ltd. (LPL), Ahmedabad based world class pharmaceutical company today announced the launch of Ayurvedic product ISL Granules to service mother and child healthcare segment, ISL Granules,...
19-08-2011
Bigul

Financial Results for Jun 30, 2011

 Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Period ended June 30, 2011.
12-08-2011
Bigul

Annual report for Lincoln Pharmaceuticals Ltd. for FY-2011
07-07-2011
Bigul

Fixes Book Closure for Dividend & AGM

 Lincoln Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2011 to September 30, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company.
02-07-2011
Bigul

Results Press Release

 Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Results Press Release".
01-06-2011
Bigul

Board recommends Dividend

 Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, has recommended the payment of Dividend of Rs. 0.60 per equity share (@ 6%) of face Value of Rs. 10/- each of the Company. for the year 2010-11, subject to approval of the shareholders in the Annual General Meeting.
31-05-2011
Bigul

Financial Results for Mar 31, 2011

 Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Period ended March 31, 2011.
31-05-2011
Bigul

Lincoln Pharmaceuticals Ltd launches Antimalarial drug 'ARH 1' developed with innovative dose optimization technology, for the first time in the world

 Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Lincoln Pharmaceuticals Ltd launches Antimalarial drug 'ARH 1' developed with innovative dose optimization technology, for the first time in the world". (For more details kindly refer Corporate Announcements on www.bseindia.com).
19-05-2011
Bigul

Board to consider Dividend

 Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2011, to approve audited financial result for the quarter / year ended March 31, 2011 and to declare dividend, if any.
09-05-2011
Bigul

Disclosures under Reg. 8A of SEBI (SAST) Regulations, 1997

 Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 8A of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSEDate of Reporting : April 30, 2011Name of the Company : Lincoln Pharmaceuticals LtdTotal no of outstanding shares of the Company : 16310800Name of the Entity : Gulabdas I Patel...
30-04-2011
Next Page
Close

Let's Open Free Demat Account